期刊文献+

高通量血液透析对维持性透析患者心血管并发症影响的临床观察 被引量:11

Clinical observation of effect of high-flux hemodialysis on cardiovascular complication of maintenance dialysis patients
原文传递
导出
摘要 目的初步探讨高通量血液透析(high-flux hemodialysis,HFD)对维持性血液透析患者(maintence hemodialysis,MHD)心血管疾病的影响,为临床提供资料。方法将武警北京市总队第三医院44例MHD患者随机分为两组:常规血液透析组(hemodialysis,HD组)20例,高通量血液透析组(HFD组)24例。分别在0、6、12个月时观察两组患者的临床症状,并检测血红蛋白、肌酐、尿素氮、白蛋白、血磷、β2-微球蛋白、甲状旁腺激素、C-反应蛋白等指标;心脏超声检测心脏左室收缩末期内径、左室舒张末期内径、舒张早期、舒张晚期二尖瓣口最大血流速度比,计算心功能指数、左室射血分数,并对结果进行对比分析。结果 HFD组对高血压、心肌缺血的疗效优于HD组,对心律失常的疗效两组比较差异;HFD组左心室腔径明显缩小,射血分数、心脏指数增加,与HD组比较差异有统计学意义(P<0.05)。结论 HFD可以明显改善MHD患者的心功能,减少心血管并发症的发生。 Objective To investigate the influence of high-flux hemodialysis(HFD) on cardiovascular diseases(CAD)of maintenance hemodialysis(MHD) patients,and provide information for clinic.Methods Forty-four patients with maintenance hemodialysis were randomly divided into HD group(20 cases) and HFD group(24 cases).The clinical symptoms were observed at 0,6 and 12 months,Hb,Cr,BUN,ALB,P3-,β2-MG,iPTH,CRP and other biochemical indices were measured at the same time,left ventricular end systolic diameter(LVESD),left ventricular end diastolic diameter(LVEDD),Peak E,Peak A,E/A ratio were measured by echocardiogram,and the heart function index(CI),left ventricular ejection fraction(EF) were calculated,then the obtained data were analysed.Results HFD group was superior to HD group on the curative effect of hypertension and myocardial ischemia,but there was no significant difference on arrhythmia between the two groups,in the HFD group,left ventricular cavity size was reduced,ejection fraction and cardiac index were increased,as compared with HD group,the differences were significant(P〈0.05).Conclusion HFD can improve the heart function of patients with MHD obviously,and reduce the occurrence of cardiovascular complications.
出处 《临床医学》 CAS 2012年第5期26-28,共3页 Clinical Medicine
关键词 高通量血液透析 血液透析 心血管疾病 High flux hemodialysis Haemodialysis Cardiovascular diseases
  • 相关文献

参考文献7

  • 1王质刚.血液净化学[M].3版.北京:北京科学技术出版社,2009:883.
  • 2John Feehally, Jtirgn Floege, Richard J Johnson. Comprehensive clinical nephrology[ M ]. 3rd edition. Philadelphia: Mesby, 2007:839 - 853.
  • 3董捷,王海燕.腹膜透析患者慢性炎症状态与营养不良及心血管病的关系[J].中华肾脏病杂志,2002,18(5):317-321. 被引量:59
  • 4季大玺.高通量血液透析的可能益处[J].中国血液净化,2005,4(7):349-351. 被引量:76
  • 5William F, Owen Jr, Brian J, et al. Dialysis and Transplantation[M].北京:科学出版社,2001:224.
  • 6Akdag I, Yilmaz Y, Kahvecioglu S, et al. Clinical value of the mal- nutrition-inflammation-atherosclerosis syndrome for long-term predic- tion of cardiovascular mortality in patients with end-stage renal dis- ease: a 5-year prospective study [ J ]. Nephron Clin Pract, 2008, 108(3) :99 - 105.
  • 7Qureshi AR, Alvestrand A, Divino-Filho JC. et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodi- alysis patients [ J]. J Am Soc Nephml, 2002 (13) :528 -536.

二级参考文献27

  • 1龚德华,季大玺,谢红浪.高通量透析器复用的研究[J].医学研究生学报,2000,13(5):307-310. 被引量:26
  • 2Jacobs C, Kjellstrand CM, Koch KM, et al. Keplacement of renal function by dialysis. 4th Revised Edition, Mrtherland:Lluwer Academic publisher, 1996,432
  • 3Ley poldt JK, Cheung AK, Clark WR,et al. Characteriza tion of low and high-flux dialyzers NIH HEMO study:Interim report(Abstract). J Am Soc Nephrol,1996,7:1518
  • 4K linkmann H, Vienken J. Membranes of dialysis, Nephrol Dia Transplant, 1995,(10)S3:39
  • 5Leto E, Bilal F, Osmic I. Efficiency of high-flux dialysis in removal of beta-mcroglobulin. Med Ash, 2001, 55(4):225
  • 6Schiffl H, Fischer R, Lang SM, et al. cliniCal manifes tations of AB-anyloidosis:effeets of biocompatibility and flux. Nephrol Dia Transplant, 2000,15:840
  • 7Kucharska E, Stompor T, Salowicz W, et al. Kenal osteodystrophy in dialysis patients as estimated by three-point bone densitometry. Prezgl Lek, 2000, 57(6):334
  • 8Lugon JR, Andre ME, Duarte ME, et al. Effects of in center daily hemodialysis upon mineral metabolism and bone disease in and stage renal disease patients. Sao Paulo Med J, 2001,119(3):105
  • 9Otsubo Y, Uchiday, Yasumoto Y, et al. ApoC Ⅲ is a potent factor on lipid abnormalities in hemodi-alysis patients. J Am Soc Nephrol, 1993,4:375 (abstract)
  • 10Dumler F, Stalla K, Mohini R, et al. CliniCal experience with short time hemodialysis. AmJ Kidney Dis, 1992,19:49

共引文献135

同被引文献90

  • 1彭隽,兰天飙,车华,余爱荣.ARB和ACEI维持性血液透析患者EPO疗效比较[J].药物流行病学杂志,2006,15(1):8-10. 被引量:4
  • 2李清芹,王玉新,陆元善,徐琴君.106例血液透析患者心血管疾病的危险因素分析[J].临床内科杂志,2006,23(6):400-402. 被引量:6
  • 3阮建平,陈华基,张铿,张卫,王晓鸣.三种血液净化治疗尿毒症透析后心包炎的对照研究[J].现代医院,2006,6(7):68-70. 被引量:1
  • 4栗明,蒋更如.高低通量血液透析膜清除溶质能力的比较[J].中国组织工程研究与临床康复,2007,11(31):6207-6210. 被引量:16
  • 5黎磊石,刘志红.中国肾脏病学[M].北京:人民军医出版社.2008:1270.
  • 6Heerspink H J, Ninomiya T, Zoungas S, et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis:a systematic review and recta-analysis of randomised controlled trials [J]. Lancet, 2009, 373 (9668) : 1009- 1015.
  • 7Zheng S, Nath V, Coyne D W. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients[J]. Am J Nephrol,2007,27(5) :522-529.
  • 8Ram C V,Fenves A Z. Management of hypertension in hemodialysis patients[J]. Curr Hypertens Rep, 2009,11 (4) : 292-298.
  • 9郑法雷,章友康,陈香美,等.肾脏病临床与进展[M].北京:人民军医出版社,2006.278-286.
  • 10Buemi M, Coppolino G, Bolignano D, et al. Arrhythmias and hemodialysis:role of potassium and new diagnostic tools[J]. Renal Failure, 2009,31 (1) : 75-80.

引证文献11

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部